Answers are grounded in this paper and cite their sources.
Advances in the management of multiple myeloma M ultiple myeloma (MM) is a bone marrow-based malignancy of plasma cells that is diagnosed in over 30,000 patients annually in the United States. Despite the many recent advances in the treatment of MM, it remains an incurable disease. Tus, the need for the development of new efective therapies remains critical for these patients.
No takes yet. Share an insight, caveat, or question.
Berenson et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: